Jump to content
  • Sign Up
Scott Adams

ImmusanT begins trials of celiac vaccine - Mass High Tech

Rate this topic

Recommended Posts

Mass High Tech

ImmusanT begins trials of celiac vaccine

Mass High Tech

Early-stage biotech business ImmusanT has started clinical trials in New Zealand, Australia and the U.S. to test Nexax2, a vaccine to treat patients with celiac disease, a condition that damages the lining of the small intestines and prevents it from ...

ImmusanT starts trials on celiac disease vaccine Boston Herald

Celiac Disease More Prevalent in North Indian, Asian Populations Celiac.com

ImmusanT Initiates Clinical Trials of Nexvax2 Therapeutic Vaccine for Celiac ... Sacramento Bee

Fast Casual (blog)  - Lincoln Journal Star

all 15 news articles »

View the full article

Share this post

Link to post
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now